Sayde Djanklich

  • Designation: Oncologist in National Cancer Center (Uzbekistan)
  • Country: Uzbekistan
  • Title: Epidemiology of Malignant Tumors in Uzbekistan


Dr. Sayde Djanklich is a graduate of the Ph.D. in Oncology, at Tashkent medical Academy. After earning a Master's in Oncology, her journey continued with residency training at the National Cancer Center in Uzbekistan. From 2021 she is Oncologist at National Cancer Center in Uzbekistan. She is a member of the Young Oncologist Association at the National Cancer Research Centre, Uzbekistan, ESMO, ESO, and IGCS. 


The purpose of the study was to analyze cancer morbidity and mortality in the Republic of Uzbekistan for 2013-2022 yy. We collected cancer incidence and mortality data from official statistics in Uzbekistan for the years 2013–2022.

The results of the study showed, that the cancer incidence of Uzbek population (including basal cell skin cancer) increased over 2013-2022 by 31.8%. Thus, the number of newly diagnosed patients with malignant tumors over the last 10 years has increased from 20,003 to 26,367 cases, and the incidence rate per 100,000 population has increased from 66,9 to 73,2. The most commonly diagnosed cancer for both sexes in the country is breast (17,2%), followed by stomach (7,9%) and cervical (7,1%) cancer. Meanwhile, for men the most frequently occurring cancers are stomach (11,8%), lung (10,7%), and colorectal cancer (9,9%), and for women: breast (28,1%), cervical (11,9%), and ovarian (6,6%) cancer. In turn, the number of death cases from cancer over 2013-2022 raised from 11,249 to 13, 888 (by 23.4%). The mortality rate per 100,000 population over 2013-2022 has increased from 37,2 to 38,6. Breast (12,9%), stomach (10,1%), and lung (8,2%) cancers remained the leading cause of cancer death for both sexes in Uzbekistan. In men stomach (13,8%), lung (12,7%), and colorectal (8,7%) cancer are the main cause of death, and in women: breast (23,4%), cervical (12,7%), and stomach (7,1%). In 2022, 49.1% of cancer cases were detected in the early stages (I-II st) (2013 y -31,9%), and almost 44% of cancer cases (2013 y-64,8%) were diagnosed in advanced stages of the disease.

In conclusion, it can be noted, that cancer incidence and mortality continue to increase in Uzbekistan. Moreover, over the past decade, the state of the oncological service has improved significantly due to the improvement in the quality of healthcare, medical equipment, and implementation of guidelines for the diagnosis and treatment of oncological patients. 

Don't miss our future updates!

Get in Touch